| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $7,562,301 ) |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY038190 | Elucidating the molecular mechanisms of secondary cone degeneration in models of Retinitis Pigmentosa | 000 | 1 | NIH | 4/2/2026 | $663,406 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC016079 | Middle Ear Nonlinearity in High Intensity Sound: Impact on Hearing Damage and Protection | 000 | 10 | NIH | 3/20/2026 | $402,788 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY030973 | Characterization and Assessment of Higher-order Visual Dysfunction in Cerebral Visual Impairment | 002 | 6 | NIH | 4/2/2026 | $760,499 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC021996 | Advancement of an Implantable Microphone | 000 | 2 | NIH | 4/1/2026 | $635,927 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K08DC022696 | The Phex Pathway: Mechanisms Underlying a Meniere's Disease Subtype | 000 | 2 | NIH | 4/1/2026 | $194,400 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K00DA060571 | Characterizing enhancers regulating transcription factor expression for cell-type specification across neurodevelopment | 003 | 4 | NIH | 1/30/2026 | $93,536 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC021439 | Development and Plasticity of Neural Circuits Underlying Sound Encoding | 000 | 3 | NIH | 4/7/2026 | $606,444 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EB036978 | Fluorescence lifetime-based intraoperative imaging system for sarcoma surgeries | 000 | 2 | NIH | 12/22/2025 | $480,039 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | P01AI083214 | Harvard-wide Program on Antibiotic Resistance | 000 | 18 | NIH | 1/23/2026 | $2,229,808 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC018353 | Diverse Cortical Layer 1 Circuits forAuditory Processing and Plasticity | 000 | 6 | NIH | 1/20/2026 | $554,078 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K23EY035734 | Clinical and functional assessment of glaucoma-associated mitochondrial gene variants to facilitate precision eye care | 000 | 3 | NIH | 12/4/2025 | $269,782 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC000188 | Cochlear synaptopathy in noise-induced and age-related hearing loss: mechanisms and treatments | 000 | 45 | NIH | 2/10/2026 | $671,763 |
| | 2026 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K08DC019128 | Neural Mechanisms Underlying the Auditory Phenotype of Mild Traumatic Brain Injury | 000 | 5 | NIH | 2/25/2026 | $0 |
| | 2026 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U01TR005352 | AAV-mediated editing to treat human autosomal dominant hearing loss DFNA41 and DFNA2 | 000 | 2 | NIH | 3/3/2026 | $0 |
| | 2026 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY022305 | NEIGHBORHOOD Consortium for POAG Genetics | 000 | 13 | NIH | 1/13/2026 | $0 |
| | 2026 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R00MH127471 | Distributed Neural Activity Patterns Underlying Practice-Based Learning | 000 | 3 | NIH | 1/16/2026 | $0 |
| | 2026 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U01DP006822 | DP24-081 The Glaucoma and Retinopathy Screening Study | 01 | 2 | CDC | 11/13/2025 | $0 |
| | 2026 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K23DE029811 | Dissecting temporal and spatial dynamics of immunotherapy resistance | 000 | 5 | NIH | 1/23/2026 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY030973 | Characterization and Assessment of Higher-order Visual Dysfunction in Cerebral Visual Impairment | 001 | 5 | NIH | 3/25/2026 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K08DC018575 | Mechanisms of Conductive Presbycusis in Humans | 000 | 5 | NIH | 1/22/2026 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC009836 | Activity-Dependent Influences on Auditory Circuits | 000 | 15 | NIH | 3/11/2026 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K08EY031759 | The Fibrosis-Immunity Interface in Corneal Transplantation | 000 | 5 | NIH | 1/6/2026 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY030088 | Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration | 000 | 5 | NIH | 3/16/2026 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U01DP006822 | DP24-081 The Glaucoma and Retinopathy Screening Study | 01 | 2 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U01DP006822 | DP24-081 The Glaucoma and Retinopathy Screening Study | 01 | 2 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R13EY036277 | Advancing Eye Health through Data Science and Artificial Intelligence | 000 | 1 | NIH | 3/17/2026 | -$169 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY030973 | Characterization and Assessment of Higher-order Visual Dysfunction in Cerebral Visual Impairment | 000 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2023 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U24DC013983 | NIDCD National Temporal Bone Hearing and Balance Pathology Resource Registry | 000 | 10 | NIH | 11/20/2025 | $0 |
| | 2026 | 2021 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC012545 | Central mechanisms and treatment response of sodium oxybate in spasmodic dysphonia and voice tremor | 000 | 10 | NIH | 1/5/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $33,221,250 ) (Continued on the next page) |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC020190 | Development of Gene Therapy for Hereditary Deafness using Rational Protein Engineering | 000 | 4 | NIH | 5/29/2025 | $655,725 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01CA260857 | Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy | 001 | 6 | NIH | 7/22/2025 | $457,001 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC021439 | Development and Plasticity of Neural Circuits Underlying Sound Encoding | 000 | 2 | NIH | 4/23/2025 | $605,722 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U01DP006822 | DP24-081 The Glaucoma and Retinopathy Screening Study | 00 | 2 | CDC | 6/18/2025 | $750,000 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01NS124228 | Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia | 000 | 3 | NIH | 4/30/2025 | $674,349 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | P50DC019900 | Next-generation clinical phenotyping and pathophysiology of laryngeal dystonia and voice tremor | 001 | 5 | NIH | 8/8/2025 | $682,489 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | P50DC015857 | Cochlear Synaptopathy: Prevalence, Diagnosis and Functional Consequences | 000 | 9 | NIH | 8/13/2025 | $2,684,343 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U24DC013983 | NIDCD National Temporal Bone Hearing and Balance Pathology Resource Registry | 002 | 10 | NIH | 1/2/2025 | $127,582 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R00MH127471 | Distributed Neural Activity Patterns Underlying Practice-Based Learning | 000 | 3 | NIH | 9/22/2025 | $223,756 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R21DC022085 | In-silico screen and in-vivo evaluation of FDA-approved drugs to treat noise-induced hearing loss | 000 | 1 | NIH | 9/11/2025 | $473,749 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R21DC022922 | Human Organ of Corti Micromechanics | 000 | 1 | NIH | 7/23/2025 | $637,500 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | P01AI083214 | Harvard-wide Program on Antibiotic Resistance | 000 | 17 | NIH | 3/5/2025 | $2,252,080 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC000188 | Cochlear synaptopathy in noise-induced and age-related hearing loss: mechanisms and treatments | 001 | 44 | NIH | 6/9/2025 | $68,125 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K01EB037630 | Developing a library of near-infrared fluorophores for multiplexed in vivo fluorescence lifetime imaging of disease biomarkers. | 000 | 1 | NIH | 8/1/2025 | $169,543 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K23DE029811 | Dissecting temporal and spatial dynamics of immunotherapy resistance | 000 | 5 | NIH | 3/20/2025 | $173,772 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY036648 | Genetic profiling of childhood glaucoma in India | 000 | 2 | NIH | 9/19/2025 | $361,250 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | F32DC022491 | Investigating the role of tip link biophysics on MET function | 000 | 2 | NIH | 7/15/2025 | $75,520 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC021981 | Vestibular implant tested in patients with peripheral vestibular damage: effects on spatial orientation, navigation, and neuropsychologic function | 001 | 2 | NIH | 8/6/2025 | $112,008 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC021981 | Vestibular implant tested in patients with peripheral vestibular damage: effects on spatial orientation, navigation, and neuropsychologic function | 000 | 2 | NIH | 7/30/2025 | $509,361 |
|
